David Soergel's most recent trade in Madrigal Pharmaceuticals Inc was a trade of 12,839 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Madrigal Pharmaceuticals Inc | David Soergel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 12,839 | 12,839 | - | - | Stock Option (Right to Buy) | |
Madrigal Pharmaceuticals Inc | David Soergel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 7,545 | 7,545 (0%) | 0% | 0 | Common Stock |